Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8676236 | Revista Colombiana de Cardiología | 2017 | 9 Pages |
Abstract
The suspension of dual antiplatelet therapy before twelve months in patients with a stent implant posterior to an acute coronary syndrome is frequent and does not seem to be associated to a higher incidence of major adverse cardiovascular events; nevertheless, the reason for the interruption could influence the clinical outcome and must be taken into account for clinical practice.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Jorge Guillermo Velásquez, Fernando Guerrero Pinedo, Mayra Alejandra Estacio, Isabela Vergara, Sebastián Yara, Diana Cristina Carrillo,